Mechanism and function of a newly identified CpG DNA moth in human primary B cells

被引:518
作者
Hartmann, G
Krieg, AM
机构
[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[2] Vet Affairs Med Ctr, Iowa City, IA 52246 USA
[3] CpG Immunopharmaceut GmbH, Hilden, Germany
[4] CpG ImmunoPharmaceut Inc, Wellesley, MA 02481 USA
关键词
D O I
10.4049/jimmunol.164.2.944
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The vertebrate immune system recognizes bacterial DNA based on the presence of unmethylated CpG-dinucleotides in particular base contexts ("CpG motifs"), In contrast to mice, knowledge about CpG-mediated effects on human B cells is poor. In the present study we identify and determine an optimal human CpG motif. A phosphodiester oligonucleotide containing this motif strongly stimulated CD86, CD40, CD54, and MHC class II expression, IL-6 synthesis, and proliferation of primacy human B cells, These effects required internalization of the oligonucleotide and endosomal maturation. The molecular mechanism of action of this CpG motif was associated with the sustained induction of the NF-kappa B p50/p65 heterodimer and of the transcription-factor complex AP-1, Transcription-factor activation by CpG DNA was preceded by increased phosphorylation of the stress kinases c-Jun N-terminal kinase and p38, and of activating transcription factor-2, In contrast to CpG, signaling through the B cell receptor led to activation of extracellular receptor kinase and to phosphorylation of a different isoform of c-Jun N-terminal kinase, These studies define the structure of a highly active human CpG moth and characterize its molecular mechanism of action in primary human B cells.
引用
收藏
页码:944 / 952
页数:9
相关论文
共 45 条
[1]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[2]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[3]   B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1 [J].
Branda, RF ;
Moore, AL ;
Hong, R ;
McCormack, JJ ;
Zon, G ;
CunninghamRundles, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 79 (02) :115-121
[4]   Amplification of antibody production by phosphorothioate oligodeoxynucleotides [J].
Branda, RF ;
Moore, AL ;
Lafayette, AR ;
Mathews, L ;
Hong, R ;
Zon, G ;
Brown, T ;
McCormack, JJ .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (03) :329-338
[5]   IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J].
BRANDA, RF ;
MOORE, AL ;
MATHEWS, L ;
MCCORMACK, JJ ;
ZON, G .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2037-2043
[6]   PERVASIVE CPG SUPPRESSION IN ANIMAL MITOCHONDRIAL GENOMES [J].
CARDON, LR ;
BURGE, C ;
CLAYTON, DA ;
KARLIN, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3799-3803
[7]   Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12 [J].
Chace, JH ;
Hooker, NA ;
Mildenstein, KL ;
Krieg, AM ;
Cowdery, JS .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (02) :185-193
[8]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[9]  
Cowdery J, 1996, J IMMUNOL, V156, P4570
[10]  
Davis HL, 1998, J IMMUNOL, V160, P870